Zalicus and Novartis extend oncology research collaboration

Zalicus provided an update today on its research collaboration with Novartis, based on its combination High Throughput Screening platform. Based on the success of the collaboration up to this point, Novartis has exercised its second option to extend its oncology discovery research collaboration with Zalicus for an additional contract year, through April 2013.